Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MT-ND1 pseudogene is a nonfunctional segment of DNA with sequence similarity to the functional mitochondrial gene MT-ND1, which encodes a subunit of the enzyme NADH dehydrogenase (Complex I) in the mitochondrial respiratory chain. Due to disruptive mutations, the pseudogene cannot produce a functional protein product. While most pseudogenes lack biological activity, some may be transcribed or have potential regulatory roles as non-coding RNAs, though such functions are rare and not well established for MT-ND1 pseudogene in particular[1][4][5][3]. Summary points: - MT-ND1 pseudogene is not a therapeutic target; it is a defunct, non-coding copy related to the MT-ND1 mitochondrial gene. - There is no evidence for drug interaction or direct involvement in disease or cellular function. - It is incorrect to consider MT-ND1 pseudogene as a valid drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene.